The Surgical Management of Medullary Thyroid Cancer

被引：16
|
作者：
Dackiw, Alan P. B. [1 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Div Endocrine & Oncol Surg, Dept Surg,Sect Endocrine Surg,Johns Hopkins Hosp, Baltimore, MD 21287 USA
来源：
OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA | 2010年 / 43卷 / 02期
关键词：
Medullary thyroid cancer; Treatment guidelines; Evidence-based treatment; Surgical techniques; DNA testing; Prognosis; Thyroidectomy; ENDOCRINE NEOPLASIA TYPE-2A; PROGNOSTIC-FACTORS; CARCINOMA; REOPERATION; RECURRENT; METASTASES; PERSISTENT; GUIDELINES; STRATEGY; STAGE;
D O I：
10.1016/j.otc.2010.01.006
中图分类号：
R76 [耳鼻咽喉科学];
学科分类号：
100213 ;
摘要：
Medullary thyroid cancer (MTC), accounts for approximately 5% to 10% of all thyroid cancers. Significant advances in the understanding of the biology and clinical outcomes of MTC have been made over the last decade, culminating most recently in the publication of treatment guidelines by the American Thyroid Association that follow an evidence-based approach that is summarized in this presentation. Prognosis, genetic testing, surgical technique, and re-operation are also discussed.
引用
收藏
页码：365 / +
页数：11
相关论文
共 50 条
  • [21] Persistent hypercalcitoninemia in patients with medullary thyroid cancer
    Misso, Claudia
    Calzolari, Filippo
    Puxeddu, Efisio
    Lucchini, Roberta
    Monacelli, Massimo
    Giammartino, Camillo
    Sanguinetti, Alessandro
    d'Ajello, Michele
    Ragusa, Mark
    Avenia, Nicola
    TUMORI, 2009, 95 (04) : 484 - 487
  • [22] Management of microcarcinomas (papillary and medullary) of the thyroid
    Wu, Leslie S.
    Milan, Stacey A.
    CURRENT OPINION IN ONCOLOGY, 2013, 25 (01) : 27 - 32
  • [23] Surgical De-Escalation in Medullary Thyroid Cancer: A Commentary
    Ginzberg, Sara P.
    Krumeich, Lauren N.
    ONCOLOGIST, 2023, : 1017 - 1019
  • [24] Systemic treatment and management approaches for medullary thyroid cancer
    Ernani, Vinicius
    Kumar, Mukesh
    Chen, Amy Y.
    Owonikoko, Taofeek K.
    CANCER TREATMENT REVIEWS, 2016, 50 : 89 - 98
  • [25] Current management of medullary thyroid cancer
    Sippel, Rebecca S.
    Kunnimalaiyaan, Muthusamy
    Chen, Herbert
    ONCOLOGIST, 2008, 13 (05) : 539 - 547
  • [26] Management of advanced medullary thyroid cancer
    Hadoux, Julien
    Pacini, Furio
    Tuttle, R. Michael
    Schlumberger, Martin
    LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (01) : 64 - 71
  • [27] Medullary thyroid cancer: molecular factors, management and treatment
    Pavlidis, Efstathios
    Sapalidis, Konstantinos
    Chatzinikolaou, Fotios
    Kesisoglou, Isaak
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2020, 61 (03) : 681 - 686
  • [28] Current management of medullary thyroid cancer
    Milan, S. A.
    Sosa, J. A.
    Roman, S. A.
    MINERVA CHIRURGICA, 2010, 65 (01) : 27 - 37
  • [29] Vandetanib in Advanced Medullary Thyroid Cancer: Review of Adverse Event Management Strategies
    Grande, Enrique
    Kreissl, Michael C.
    Filetti, Sebastiano
    Newbold, Kate
    Reinisch, Walter
    Robert, Caroline
    Schlumberger, Martin
    Tolstrup, Laerke K.
    Zamorano, Jose L.
    Capdevila, Jaume
    ADVANCES IN THERAPY, 2013, 30 (11) : 945 - 966
  • [30] Medullary thyroid cancer: an update of new guidelines and recent developments
    Wu, Leslie S.
    Roman, Sanziana A.
    Sosa, Julie A.
    CURRENT OPINION IN ONCOLOGY, 2011, 23 (01) : 22 - 27
12345